Rapport Therapeutics logo
Rapport Therapeutics
RAPP | NASDAQ
Chart Builder DCF Calculator
$24.82
-$1.33 (-5.09%)
At close: Nov 16, 2026, 4:00 PM ET
$24.39
-$0.43 (-1.73%)
After-hours: Nov 16, 2026, 7:30 PM ET

Rapport Therapeutics Institutional Ownership

Institutional ownership explained

Institutional Ownership

Net Outflow
Dollar & Volume Weighted
Total Institutions
166
Total Ownership
109.07%
Capital Flow
-$498.02M
Shares Change
-964.26K
Ownership Distribution
Institutions (99.99%)
Others (0.01%)

Institutional Sentiment

Overall: neutral
Equity Sentiment & Activity
bullish
New Positions
32
Increased Positions
88
Reduced Positions
47
Closed Positions
15
New (32)
Increased (88)
Reduced (47)
Closed (15)
Options Sentiment & Activity
bearish
Put/Call Ratio
1.241
Call Flow
8,700
Put Flow
10,800
Calls (45%)
Puts (55%)

Super Investors

Super Investor / Fund Ownership Portfolio Weight Shares Market Value
Renaissance Technologies LLC
0.02%
-91.84%
< 0.01%
9.7K
462.98K

Top Shareholders

Institution Ownership Portfolio Weight Shares Market Value
FMR LLC
15.11%
-0.44%
0.01%
+9.80%
7.17M
+0.06%
298.89M
+33.25%
Trv Gp V, LLC
13.23%
-12.42%
52.53%
-5.66%
6.28M
-11.98%
261.71M
+17.22%
Arch Venture Management, LLC
7.85%
-0.50%
14.12%
-18.05%
3.73M
0.00%
155.38M
+33.17%
Pro Membership

Stop Guessing, Start Knowing.

Cut through market noise with actionable insights that actually help you make confident investment decisions. No more endless research or gut-based guessing.

Unlimited access

Unlimited access to all data and tools, giving you the edge over everyone else in the market.

Proprietary Stock Rating Score

Evaluate stocks with our proprietary rating score based on fundamentals, economic moat, and sentiment.

Top Wall Street Analyst Ratings

Follow ratings from the best analysts on Wall Street to stay ahead of market moves.

Up to 30 years financial history

We deliver premium Wall Street data with top-tier accuracy and up to 30 years of history.

© 2026 bestshares.com. All rights reserved.

All data is for informational purposes only. bestshares.com is not a broker, dealer, or registered investment adviser, and nothing on this site is a recommendation to buy or sell any security.